Correlation Between Vaxart and Diffusion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Vaxart and Diffusion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaxart and Diffusion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaxart Inc and Diffusion Pharmaceuticals, you can compare the effects of market volatilities on Vaxart and Diffusion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaxart with a short position of Diffusion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaxart and Diffusion Pharmaceuticals.
Diversification Opportunities for Vaxart and Diffusion Pharmaceuticals
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Vaxart and Diffusion is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Vaxart Inc and Diffusion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Diffusion Pharmaceuticals and Vaxart is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaxart Inc are associated (or correlated) with Diffusion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Diffusion Pharmaceuticals has no effect on the direction of Vaxart i.e., Vaxart and Diffusion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Vaxart and Diffusion Pharmaceuticals
Given the investment horizon of 90 days Vaxart Inc is expected to generate 1.68 times more return on investment than Diffusion Pharmaceuticals. However, Vaxart is 1.68 times more volatile than Diffusion Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Diffusion Pharmaceuticals is currently generating about -0.11 per unit of risk. If you would invest 114.00 in Vaxart Inc on August 29, 2024 and sell it today you would lose (53.00) from holding Vaxart Inc or give up 46.49% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 31.45% |
| Values | Daily Returns |
Vaxart Inc vs. Diffusion Pharmaceuticals
Performance |
| Timeline |
| Vaxart Inc |
| Diffusion Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Vaxart and Diffusion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vaxart and Diffusion Pharmaceuticals
The main advantage of trading using opposite Vaxart and Diffusion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaxart position performs unexpectedly, Diffusion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diffusion Pharmaceuticals will offset losses from the drop in Diffusion Pharmaceuticals' long position.The idea behind Vaxart Inc and Diffusion Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Diffusion Pharmaceuticals vs. Bio Path Holdings | Diffusion Pharmaceuticals vs. Capricor Therapeutics | Diffusion Pharmaceuticals vs. NextCure | Diffusion Pharmaceuticals vs. Tonix Pharmaceuticals Holding |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |